A TP is the crucial universal energy carrier in cellular respiration, 1 thus intracellular concentrations can reach up to 8 mmol/L. Of note, many forms of cellular irritation such as cell death, hypoxia, or inflammation promotes the release of ATP from intracellular storage pool into the extracellular compartment. Thereby active and passive modes can be involved; for instance, platelet aggregation triggers ATP release via vesicular release, whereas activated neutrophils can spill ATP via connexin hemichannels. Pannexin channels seem to be one of the major modes of ATP release from apoptotic cells. Once in the extracellular compartment, ATP can bind to purinergic receptors acting either as a find-me signal or danger signal modulating/inducing inflammatory responses. [2] [3] [4] [5] Purinergic receptors are almost ubiquitously expressed in all kinds of tissues and contribute to innate and adaptive immunity. 6,7
receptor P2Y 6 contributes to experimental atherosclerosis. 19 P2Y 12 antagonists such as clopidogrel, prasugrel, or ticagrelor are clinically used in patients with coronary heart disease to inhibit platelet aggregation. 20, 21 But beyond its role in platelet aggregation, P2Y 12 -deficient mice are protected from vascular inflammation and atherosclerosis. 22, 23 Extracellular ATP and UTP activate equipotentially mitogen-activated protein kinases via the purinergic receptor P2Y 2 . 24 The ATP-P2Y 2 interaction increases levels of chemokines such as keratinocyte-derived chemokine and macrophage inflammatory protein 2 levels, and P2Y 2 -deficient mice express reduced vascular cell adhesion molecule 1 (VCAM-1). [25] [26] [27] [28] Thus, activation of the ATP-P2Y 2 axis guides leukocyte to sites of inflammation.
Because leukocyte recruitment to the vessel wall is a crucial step in atherogenesis, 29, 30 we hypothesized that extracellular ATP plays an important role in leukocyte recruitment to the inflamed vessel wall and atherosclerosis via P2Y 2 , and that P2Y 2 deletion limits experimental atherosclerosis. 1 . Extracellular ATP in leukocyte recruitment. C57/BL6 mice were stimulated with thioglycolate intraperitoneally for induction of sterile peritonitis. ATP (100 nmol) was injected additionally in the peritoneal cavity (ATP group), PBS served as control (PBS). Peritoneal leukocytes were counted after 4 h (A). C57/BL6 mice were intraperitoneally stimulated with either PBS or 100 nmol ATP. Intravital microscopy of mesenteric vessels was performed after 2 hours, and leukocyte rolling and adhesion were measured (B). Representative images are shown in C. Adherent cells to mesenterial vessels were determined with intravital microscopy after stimulation with increasing doses of ATP (D). CX3CR1-GFP (green fluorescence protein) mice were intraperitoneally stimulated with either PBS or 100 nmol ATP. Intravital microscopy was performed after 2 hours, and leukocyte rolling and adhesion were measured (E). Data are presented as pooled mean±SEM. Statistical analysis used the Student 2-tailed t test for paired or unpaired values.
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Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
Extracellular ATP Induces Leukocyte Rolling, Adhesion, and Migration
Leukocyte recruitment to the vessel wall is a crucial step in atherogenesis. To elucidate the role of extracellular ATP in leukocyte migration to the site of inflammation, sterile peritonitis was induced in C57/BL mice. Whenever extracellular ATP was injected into mice, significantly more leukocytes entered the peritoneal cavity compared with saline-injected control mice ( Figure 1A ). Intravital microscopy of mesenteric vessels was performed to functionally dissect leukocyte recruitment after ATP stimulation. Extracellular ATP induced both leukocyte rolling and adhesion ( Figure 1B and 1C ). ATP-mediated leukocyte adhesion proved to be dose-dependent because more leukocytes adhered with increasing doses of ATP ( Figure 1D ). Because monocytes are the predominant leukocyte cell fraction recruited into the atherosclerotic vessel wall, we evaluated the role of extracellular ATP in monocyte recruitment by intravital microscopy of CX3CR-1-GFP (green fluorescence protein) mice. In accord with the previous findings, extracellular ATP promoted monocyte rolling and adhesion to the vessel wall ( Figure 1E ).
Atherogenesis Increases Plasma Level of Extracellular ATP
To elucidate the contribution of extracellular ATP in atherosclerosis, ATP levels were measured in nonatherosclerotic low-density lipoprotein receptor (LDLR) −/− mice consuming a chow diet and atherosclerotic LDLR −/− mice consuming high cholesterol diet (HCD). After 8 weeks of HCD, animals showed atherosclerotic lesions in the aortic arch. The plasma levels of ATP were significantly higher in atherosclerotic mice (492±57 nmol/L) than in chow fed nonatherosclerotic mice (263±70 nmol/L; P=0.04; Figure 2A ).
Extracellular ATP Promotes Atherosclerosis
Because extracellular ATP increased during atherogenesis and induced monocyte rolling and adhesion, we hypothesized a role for extracellular ATP in atherogenesis. LDLR −/− mice consumed HCD. ATP or saline was injected 3× per week. After 16 weeks of treatment, ATP-stimulated mice developed significantly increased atherosclerotic lesions in the aortic arch (n=13; control group, 0.26 mm 2 ; ATP group, 0.33 mm 2 ; P=0.01) and the abdominal aorta (n=13; control group, 0.20 mm 2 ; ATP group, 0.38 mm 2 ; P<0.0001) compared with salinestimulated animals ( Figure 2B through 2D).
Analyzing the plaque composition by immunohistochemistry revealed ATP as a mediator of plaque inflammation. Atherosclerotic lesions of ATP-simulated LDLR −/− animals contained more macrophages (control group, 0.11 mm 2 pos. staining/total area versus 0.26 mm 2 positive staining/total area; P=0.03) without affecting content of lipids or smooth muscle cells (SMCs). Interestingly, collagen content was enhanced in atherosclerotic lesions of ATP-stimulated mice (control group, 0.006 mm 2 pos. staining/total area versus 0.012 mm 2 pos. staining/total area; P=0.04; Figure 2E ).
Leukocytes in peripheral blood, differential blood count, total cholesterol, and triglycerides did not differ in the study groups, but ATP-treated animals gained less weight during the HCD (Table 1) .
ATP-P2Y 2 Interaction Mediates Leukocyte Adhesion
Extracellular ATP binds to several purinergic receptors. It is known that ATP-P2Y 2 interaction promotes expression of cell adhesion molecules such as VCAM-1 and chemokines indicating an important role of P2Y 2 in inflammation. To test the ATP-P2Y 2 axis in vascular inflammation, P2Y 2 -deficient and competent LDLR −/− mice were stimulated IP with ATP. As shown in Figure 3 , administration of ATP in P2Y 2 -competent LDLR −/− mice again induced leukocyte rolling and adhesion. However, extracellular ATP mediated leukocyte rolling, but not leukocyte adhesion in P2Y 2 -deficient LDLR −/− mice. ATP is a subject to breakdown, and its metabolites such as ADP or AMP activate purinergic receptors. To rule out that these metabolites mediated the induction of leukocyte adhesion, P2Y 2 -competent and P2Y 2 -deficient were treated with ADP and AMP. Both metabolites slightly increased leukocyte adhesion irrespective of P2Y 2 , suggesting that the main effect was because of the administration of ATP. This suggests that the ATP-P2Y 2 interaction affects particularly leukocyte adhesion by regulating cell adhesion molecule expression in vascular inflammation ( Figure 3A and 3B).
P2Y 2 Is Expressed in Macrophages and Endothelial Cells in Atherosclerotic Plaques
Based on our finding that the ATP-P2Y 2 interaction induced leukocyte recruitment, we determined the mRNA and protein expression levels of P2Y 2 in atherosclerotic lesions. Markedly more relative P2Y 2 -mRNA was detectable in atherosclerotic vessels of LDLR −/− mice consuming HCD than in respective control mice consuming chow ( Figure 3C ). Immunohistochemistry confirmed these results ( Figure 3D and 3E).
Three color-immunofluorescence imaging revealed coexpression of the endothelial marker CD31 and P2Y 2 . However, endothelial P2Y 2 expression and amount of P2Y 2 expressing SMCs were similar in nonatherosclerotic and atherosclerotic vessels. In contrast, we observed increased numbers of P2Y 2 -expressing macrophages, suggesting that these macrophages promote enhanced atherosclerotic P2Y 2 expression ( Figure 3F and 3G).
P2Y 2 Deficiency Limits Atherosclerosis and Plaque Inflammation
To investigate the functional role of P2Y 2 in atherosclerosis, P2Y 2 -deficient animals were crossed with LDLR −/− animals. LDLR −/− littermates served as control. After 16 weeks of HCD, P2Y 2 −/− /LDLR −/− mice showed significantly smaller atherosclerotic lesions than P2Y 2 +/+ /LDLR −/− mice in the aortic arch (control group, 0.25 mm 2 ; P2Y 2 −/− group, 0.14 mm 2 ; P=0.04) and the abdominal aorta (control group, 0.14 mm 2 ; P2Y 2 −/− group, 0.04 mm 2 ; P=0.02; Figure 4A through 4C). Consistent with the results from intravital microscopy and the ATP-atherosclerosis study, atherosclerotic lesions of P2Y 2deficient mice contained less macrophages and relatively more SMCs, but similar amount of lipids. Also collagen was similar in both groups ( Figure 4D ). Leukocytes in peripheral blood, differential blood count, weight, total cholesterol, and triglycerides did not differ in the study groups ( Table 2 ). Because 
P2Y 2 Regulates Adhesion Molecule Expression
Because P2Y 2 deficiency reduced leukocyte recruitment to sites of inflammation and also the content of macrophages in atherosclerotic lesions, we determined RNA expression of chemokines and cell adhesion molecules in atherosclerotic lesions of P2Y 2 -competent and P2Y 2 -deficient mice. The expression of both adhesion molecules intercellular cell adhesion molecule (ICAM)-1 and VCAM-1 was significantly reduced in atherosclerotic lesions of P2Y 2 -deficient mice. This was confirmed by immunohistochemistry. The lesional expression of integrins lymphocyte function-associated antigen 1, very late antigen 4, L-selectin, and E-selectin were not altered, whereas P-selectin was decreased in P2Y 2 -deficient mice ( Figure 5B , representative pictures are shown in Figure I in the online-only Data Supplement). RNA of chemokines such as keratinocytederived chemokine, RANTES (regulated on activation normal T-cell-expressed and secreted), or MCP-1 (monocyte chemoattractant protein-1) was slightly decreased ( Figure 5A ).
Because atherosclerotic lesions from P2Y 2 -deficient mice contained more SMC, we investigated markers for apoptosis and proliferation in atherosclerotic lesions. No differences in KI67 or caspase-3 expression occurred between P2Y 2 -deficient and P2Y 2 -competent mice ( Figure 5C ). Furthermore, intraperitoneal stimulation with ATP induced VCAM-1 expression in aortic endothelial cells of wild-type mice, but did not in endothelial cells of P2Y 2deficient mice. E-selectin expression was slightly increased, whereas ICAM-1 and P-selectin expressions were not altered. Integrin expression on monocytes was not influenced by ATP stimulation, indicating a crucial role of the ATP-P2Y 2 axis in endothelial VCAM-1 expression ( Figure 5D ).
Discussion
The present study reports the novel finding that extracellular ATP promotes vascular inflammation and atherosclerosis, whereas the deficiency of the ATP-receptor P2Y 2 reduces both. Only few studies investigated the role of extracellular nucleotides in vascular inflammation and atherosclerosis although their proinflammatory properties are well-established. 2 Leukocyte recruitment after tumor necrosis factor-α stimulation was reduced in P2Y 1 -deficient mice. 18 Recently, we could show that extracellular UDP induced leukocyte rolling and adhesion via endothelial P2Y 6 . 19 Intraperitoneal injection of ATP enhanced total neutrophil and macrophage count in peritoneal lavage by inducing macrophage inflammatory protein 2 via P2X 7 and P2Y 2 . 25 Accordingly, P2Y 2 induced chemotaxis of human neutrophils. 28, 31, 32 In the present study, we observed increased leukocytes in thioglycolate-induced sterile peritonitis if extracellular ATP was additionally injected. To further characterize the role of extracellular ATP in leukocyte rolling and adhesion, we performed intravital microscopy. We show in vivo that extracellular ATP induced rolling and adhesion of leukocytes. Besides the role of extracellular ATP in neutrophil migration, it guides dendritic cells, macrophages, and eosinophils in allergic lung inflammation. 27, 33 We provide evidence that extracellular ATP activates monocyte rolling and adhesion, which is a crucial step in atherogenesis. 2 To gain further insight into the role of extracellular ATP in atherosclerosis, we measured plasma levels of extracellular ATP in atherosclerotic and nonatherosclerotic mice showing an increased release of ATP on development of atherosclerosis. To test the functional role of extracellular ATP in atherosclerosis, we stimulated LDLR −/− mice consuming HCD with ATPgammaS (ATPγS), a nonhydrolyzable, more stable form of ATP. The selected dose of 10 nmol is roughly equivalent to a doubling of the natural extracellular ATP concentration in plasma, which is between 400 and 700 nmol/L. 34 The intraperitoneal administration of ATP increased plasma levels from 500 to 700 nmol/L in our study compared with the control group. Mice stimulated with extracellular ATP developed larger atherosclerotic lesions although they gain less weight compared with control animals. This is in accord with a previous study showing that infusion of UTP and ATP increases intimal hyperplasia in collared rabbit carotid arteries. 35 Atherosclerotic lesions of ATP-stimulated animals are more inflamed with a higher content of macrophages. This suggests that ATP guides monocytes to the atherosclerotic lesion as we observe in intravital microscopy. Interestingly, collagen content is also increased, which could account for to a feedback mechanism to the release of ATP by dying cells. This is in line with the finding, that extracellular ATP is involved in lung and pancreas fibrotic remodeling. 36, 37 Extracellular ATP binds to all P2X-and P2Y-receptors except P2Y 6 and P2Y 14 . 2, 38 Because P2Y 2 contributes to chemokine expression such as MCP-1 or macrophage inflammatory protein 2 and cell adhesion molecule expression such as VCAM-1, 26, 39 we hypothesized that extracellular ATP induces leukocyte recruitment via P2Y 2 in vivo. Intraperitoneal stimulation of P2Y 2 -competent mice again induced leukocyte rolling and adhesion. However, in P2Y 2 -deficient mice, leukocyte adhesion was significantly reduced without affecting rolling. This can be explained by the fact that extracellular ATP regulates selectin function and thereby rolling by P2X 7 , 40,41 but increases adhesion molecule expression and thereby adhesion by P2Y 2 . Metabolites of ATP such as ADP and AMP, which activate purinergic receptors, increased leukocyte adhesion only slightly compared with ATP administration. This could not be reversed in P2Y 2 -deficient animals indicating a specific role of P2Y 2 in ATP-mediated leukocyte adhesion. Thus, we investigated the role of P2Y 2 in atherosclerosis.
To elucidate the contribution of P2Y 2 in atherosclerosis, we measured P2Y 2 expression in nonatherosclerotic and atherosclerotic vessels. P2Y 2 RNA was relatively increased in atherosclerotic lesions determined by real-time polymerase chain reaction and immunohistochemistry. Accordingly, P2Y 2 was upregulated in neointima formation in collared rabbit carotid arteries. 35 Immunofluorescence of atherosclerotic lesions imaging revealed that P2Y 2 was coexpressed with the endothelial markers CD31 and SMC α-actin in nonatherosclerotic and atherosclerotic vessels indicating a functional role of P2Y 2 in these cells, but intensity of coexpression did not significantly change during atherogenesis. However, we observe a marked increase of P2Y 2 -expressing macrophages indicating that macrophages contribute to the enhanced P2Y 2 expression in atherosclerotic lesions.
The role of danger signals such as extracellular nucleotides in atherosclerosis is not sufficiently clarified. Treatment with the broad purinergic inhibitor purinergic receptor antagonist reduced atherosclerosis in ApoE −/− mice. 42 Deficiency of P2Y 1 , P2Y 6 , or P2Y 12 receptors limited experimental atherosclerosis. 17, 19, 22 We demonstrate that P2Y 2 -deficient LDLR −/− mice develop significantly smaller plaques than P2Y 2 -competent control LDLR −/− mice. In line with the results of the intravital Before and after 16 weeks of high cholesterol diet blood was taken and total leukocytes and platelets were measured in thousand per microliter (tsd/μL). Furthermore, leukocyte subsets were determined by fluorescence-activated cell sorter analysis after diet. Weight and plasma total cholesterol were measured after diet ATP atherosclerosis study and of the intravital microscopy, atherosclerotic lesions from P2Y 2 -deficient mice contained less macrophages. Moreover, the plaque of P2Y 2 -deficient mice contained more SMCs, an effect that is most likely relative because of the reduced macrophages because we did not find differences for markers of apoptosis or proliferation in vivo. This plaque composition is associated with a more stable plaque phenotype in humans. 43 Remarkably, we found no differences in collagen content, which we observed in ATP-stimulated LDLR −/− mice. ATP binds to all P2X receptors and different P2Y receptors. Because administration of ATP to P2Y 2 -deficient animals increased atherosclerosis only slightly compared with a significant increase in P2Y 2 -competent animals, we conclude that P2Y 2 plays an important role in ATP-mediated atherogenesis.
To further clarify the mechanisms of P2Y 2 in atherosclerosis, we extracted RNA from P2Y 2 -competent and P2Y 2deficient atherosclerotic lesions. We observe a downregulation of the adhesion molecules VCAM-1, ICAM-1, and P-selectin in vivo. Particularly, VCAM-1 is known to induce leukocyte adhesion and atherosclerosis, whereas the role of ICAM-1 in atherosclerosis is controversial. [44] [45] [46] Stimulation with ATP induced VCAM-1 and E-selectin expression in aortic endothelial cell of wild-type mice, but did not alter the expression of ICAM-1 and P-selectin. However, in P2Y 2 -deficient mice, VCAM-1 expression was rarely changed indicating a crucial role of endothelial VCAM-1 in the ATP-P2Y 2 -mediated vascular inflammation. Integrin expression on monocytes remained unaffected by ATP stimulation. These experiments provide evidence that extracellular ATP attracts leukocytes to the endothelium directly via P2Y 2 .
In summary, the present study shows that (1) extracellular ATP induces leukocyte and monocyte recruitment, (2) extracellular ATP is increased released in atherosclerosis and enhances atherosclerosis via P2Y 2 , and (3) leukocyte adhesion and atherosclerosis is reduced in P2Y 2 -deficient mice by a downregulation of cell adhesion molecules. We conclude that inhibition of the ATP-P2Y 2 axis could represent a potentially fruitful target in the treatment of atherosclerotic disease and vascular inflammation.
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